aTYR PHARMA (ATYR) Other Non Operating Income (2014 - 2018)

aTYR PHARMA (ATYR) has 5 years of Other Non Operating Income data on file, last reported at -$359000.0 in Q4 2018.

• Quarterly Other Non Operating Income fell 31.02% year-over-year to -$359000.0 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was -$1.7 million (down 59.6% YoY) and the FY2018 annual result came in at -$1.7 million, down 59.6% from the prior year.
• Other Non Operating Income rose to -$359000.0 in Q4 2018, from -$437000.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $3.0 million in Q4 2015 to a low of -$452000.0 in Q2 2018.
• A 5-year average of -$40700.0 and a median of -$188000.0 in 2015 frame the typical range for Other Non Operating Income.
• Annual changes were most pronounced in 2015 — Other Non Operating Income jumped 37862.5% — and 2017, when it sank 889.13%.
• Tracing ATYR's Other Non Operating Income over 5 years: stood at -$8000.0 in 2014, then jumped by 37862.5% to $3.0 million in 2015, then tumbled by 101.95% to -$59000.0 in 2016, then sank by 364.41% to -$274000.0 in 2017, then tumbled by 31.02% to -$359000.0 in 2018.
• The last three Other Non Operating Income figures came in at -$359000.0 (Q4 2018), -$437000.0 (Q3 2018), and -$452000.0 (Q2 2018), per Business Quant data.